Memorial Sloan Kettering Cancer Center: Pancreatic Neoplasms trials

The registry lists 42 Pancreatic Neoplasms studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 7 are open to participants now and 6 have results posted.

Early Phase 1 1Phase 1 11Phase 2 10Phase 3 3No phase 18(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic CancerRecruitingNCT07671339Phase 1
• A Study of Magnetic Resonance Imaging of the Pancreas for Cancer ScreeningRecruitingNCT07612046
• A Study of Multiparametric Ultrasound Imaging MethodsRecruitingNCT07270237Not applicable
• A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueRecruitingNCT05837767Not applicable
• Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer PatientsRecruitingNCT04751435Not applicable
• A Study of Blood Based Biomarkers for Pancreas AdenocarcinomaRecruitingNCT03334708
• Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic CancerRecruitingNCT02393703
• Use of Epidurals Intraoperatively for Patients Undergoing Pancreas ResectionCompletedNCT03434678Phase 3Results posted
• Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?CompletedNCT03269994Phase 3Results posted
• Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical ResectionCompletedNCT02241187Not applicableResults posted
• Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal LavageCompletedNCT01132755Phase 2Results posted
• Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain MetastasesCompletedNCT00587964Phase 2Results posted
• Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By SurgeryCompletedNCT00536874Phase 2Results posted
• A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic CancerActive, not recruitingNCT06168812Phase 2
• PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9WithdrawnNCT05737615Phase 1
• Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)Active, not recruitingNCT05642962Phase 1/2
• Radiation Therapy (RT) and Chemotherapy for the Treatment of Pancreatic Cancer with Homologous Recombination Deficiency That Has Spread to the LiverCompletedNCT05182112Phase 1
• Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic CancerActive, not recruitingNCT05141643Early Phase 1
• Study of a New Technique for Imaging Pancreatic CancerCompletedNCT04883775Phase 1
• An Ultrasound Imaging Technique to Measure Tumors in People With Pancreatic Ductal Adenocarcinoma (PDAC) or Gastrointestinal (GI) AdenocarcinomaActive, not recruitingNCT04837833Not applicable
• A Study of the Life Changes Experienced by Patients With Pancreatic CancerActive, not recruitingNCT04427761
• Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid TreatmentCompletedNCT04210128
• Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With SurgeryActive, not recruitingNCT04161755Phase 1
• A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic CancerActive, not recruitingNCT04137536Phase 1
• Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic CancerActive, not recruitingNCT03523312Phase 2
• Predicting Effective Therapy in Pancreatic CancerActive, not recruitingNCT03033927
• Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic AdenocarcinomaActive, not recruitingNCT02921022Not applicable
• Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient OutcomesActive, not recruitingNCT02917798
• A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic CancerCompletedNCT02643498Phase 1
• Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally InvasiveCompletedNCT01262040Not applicable
• Depression, Cytokines and Pancreatic CancerCompletedNCT00582699
• Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal TractActive, not recruitingNCT00582647
• Detection of Peritoneal Micrometastasis in Gastric and Pancreatic Cancer in Peritoneal Wash SamplesCompletedNCT00582062
• Clinical Outcomes in Hereditary CancerWithdrawnNCT00580021
• Acupuncture For Pancreatic Cancer PainCompletedNCT00136669Phase 3
• Alanosine in Treating Patients With CancerCompletedNCT00062283Phase 2
• UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00045747Phase 2
• Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic CancerCompletedNCT00040833Phase 2
• Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or PancreasCompletedNCT00003923Phase 2
• Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerCompletedNCT00003427Phase 1
• Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic CancerCompletedNCT00003426Phase 1
• Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic CancerCompletedNCT00003025Phase 1